Mariners’ new manager has an ugly history with Milton Bradley

15 Comments

Now that Eric Wedge has been hired as the Mariners’ new manager Milton Bradley’s odds of playing a second season in Seattle are seemingly extremely slim. That is if they weren’t extremely slim already, of course.

Back in 2003 the Indians had Wedge as their manager and Bradley as their center fielder, and while the team wasn’t very good Bradley had one of the best seasons of his career, hitting .321/.421/.501 in 101 games.

He also reportedly clashed with Wedge on numerous occasions and their poor relationship boiled over the next spring when Wedge pulled Bradley from a spring training game for failing to run out a pop up that dropped for a hit. Bradley was barred from the Indians’ spring training complex after reportedly wearing a t-shirt in the clubhouse that read “F*** Eric Wedge” and was traded to the Dodgers a short time later.

In other words, Eric Wedge knows all about life with Milton Bradley and I can’t imagine he wants to re-live the 2003/2004 experience at his new job. Of course, the Mariners’ ability to get rid of Bradley is another issue. They have him in the first place because they agreed take him back from the Cubs in exchange for Carlos Silva’s bloated contract last offseason and since then Bradley turned in the worst year of his career, hitting .205/.292/.348 in 73 games.

He had essentially zero value–and perhaps even negative value–last offseason, so after a terrible, injury filled year the Mariners may be forced to simply cut him loose and eat the $12 million he’s owed in 2011. If they can get anything for him, or even swap him for another bad contract, general manager Jack Zduriencik and company would no doubt jump at the chance. Anything short of that would be setting Wedge up for trouble from Day 1.

MLB, union resume blood testing after pandemic, lockout

Scott Taetsch-USA TODAY Sports
1 Comment

NEW YORK – In the first acknowledgment that MLB and the players’ association resumed blood testing for human growth hormone, the organizations said none of the 1,027 samples taken during the 2022 season tested positive.

HGH testing stopped in 2021 because of the COVID-19 pandemic. Testing also was halted during the 99-day lockout that ended in mid-March, and there were supply chain issues due to COVID-19 and additional caution in testing due to coronavirus protocols.

The annual public report is issued by Thomas M. Martin, independent program administrator of MLB’s joint drug prevention and treatment program. In an announcement accompanying Thursday’s report, MLB and the union said test processing is moving form the INRS Laboratory in Quebec, Canada, to the UCLA Laboratory in California.

MLB tests for HGH using dried blood spot testing, which was a change that was agreed to during bargaining last winter. There were far fewer samples taken in 2022 compared to 2019, when there were 2,287 samples were collected – none positive.

Beyond HGH testing, 9,011 urine samples were collected in the year ending with the 2022 World Series, up from 8,436 in the previous year but down from 9,332 in 2019. And therapeutic use exemptions for attention deficit hyperactivity disorder dropped for the ninth straight year, with just 72 exemptions in 2022.

Overall, the league issued six suspensions in 2022 for performance-enhancing substances: three for Boldenone (outfielder/first baseman Danny Santana, pitcher Richard Rodriguez and infielder Jose Rondon, all free agents, for 80 games apiece); one each for Clomiphene (Milwaukee catcher Pedro Severino for 80 games), Clostebol (San Diego shortstop Fernando Tatis Jr. for 80 games) and Stanozolol (Milwaukee pitcher J.C. Mejia for 80 games).

There was an additional positive test for the banned stimulant Clobenzorex. A first positive test for a banned stimulant results in follow-up testing with no suspension.